The global psychotropic drugs market is entering a period of steady expansion as mental health conditions become a growing healthcare priority worldwide. Valued at US$ 23.1 billion in 2025, the market is projected to reach US$ 41.2 billion by 2036, advancing at a 5.4% CAGR from 2026 to 2036. Rising rates of depression, anxiety, schizophrenia, bipolar disorder, ADHD, and other psychiatric...